RAC to address accelerated review

After numerous delays, the NIH's Recombinant DNA Advisory Committee is apparently prepared to discuss ways to streamline the review process for minor changes in gene therapy protocols at its upcoming meeting scheduled for March 3-4.

RAC has been trying to find time to discuss the proposed changes since last June, but there have been too many gene therapy protocols on the docket at each meeting. The upcoming meeting has a light schedule.